Cargando…

The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK

BACKGROUND: This study characterized a cohort of chronic obstructive pulmonary disease (COPD) patients on maintenance bronchodilator monotherapy for ≥6 months to establish their disease burden, measured by health care utilization. METHODS: Data were extracted from the UK Clinical Practice Research D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edwards, Susan C, Fairbrother, Sian E, Scowcroft, Anna, Chiu, Gavin, Ternouth, Andrew, Lipworth, Brian J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125989/ https://www.ncbi.nlm.nih.gov/pubmed/27920512 http://dx.doi.org/10.2147/COPD.S109707

Ejemplares similares

Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK
por: Eklund, Oskar, et al.
Publicado: (2016)

Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective
por: Shah, Dhvani, et al.
Publicado: (2018)

First Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases
por: Bloom, Chloe I., et al.
Publicado: (2022)

Glycopyrrolate/formoterol fumarate metered dose inhaler for maintenance-naïve patients with chronic obstructive pulmonary disease: a post-hoc analysis of the randomized PINNACLE trials
por: Zheng, Jinping, et al.
Publicado: (2020)

Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study
por: Short, Philip M, et al.
Publicado: (2011)

Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK
por: Punekar, Yogesh Suresh, et al.
Publicado: (2015)

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)

Study of the burden on patients with chronic obstructive pulmonary disease
por: Izquierdo, J L, et al.
Publicado: (2009)

The disease burden of chronic obstructive pulmonary disease in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2016)

Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade
por: Adeloye, Davies, et al.
Publicado: (2021)

Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany
por: Lewis, Hannah B, et al.
Publicado: (2020)

UK-specific cost-effectiveness of tiotropium + olodaterol fixed-dose combination versus other LAMA + LABA combinations in patients with COPD
por: Tebboth, Abigail, et al.
Publicado: (2016)

The burden of chronic obstructive pulmonary disease among employed adults
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2012)

The clinical and economic burden of chronic obstructive pulmonary disease in the USA
por: Guarascio, Anthony J, et al.
Publicado: (2013)

Patient-perceived treatment burden of chronic obstructive pulmonary disease
por: Harb, Nathan, et al.
Publicado: (2017)

The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home
por: Talwar, Deepak, et al.
Publicado: (2021)

Eosinophil values in exacerbation and stable chronic obstructive pulmonary disease and its relationship to maintenance therapy in stable chronic obstructive pulmonary disease patients
por: Fachri, Muhammad, et al.
Publicado: (2023)

Symptom burden and self-management in persons with chronic obstructive pulmonary disease
por: Bringsvor, Heidi B, et al.
Publicado: (2018)

The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary Disease
por: Hong, Yoon Duk, et al.
Publicado: (2020)

The effects of maintenance schedules following pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomised controlled trial
por: Wilson, Andrew M, et al.
Publicado: (2015)

Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat(®) fixed-dose combination for chronic obstructive pulmonary disease patients in Italy
por: Selya-Hammer, Carl, et al.
Publicado: (2016)

Chronic Obstructive Pulmonary Disease: Inpatient Management
por: Harte, Brian J., et al.
Publicado: (2013)

Predictors of residual pulmonary vascular obstruction after anticoagulation monotherapy in patients with intermediate-risk pulmonary embolism
por: Chang, Youjin, et al.
Publicado: (2021)

Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of chronic obstructive pulmonary disease
por: Sharifi, Hooman, et al.
Publicado: (2015)

The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada
por: Dang-Tan, Tam, et al.
Publicado: (2017)

Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice
por: Chalmers, James D., et al.
Publicado: (2017)

Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease
por: Talman, Sander, et al.
Publicado: (2021)

Is telerehabilitation an effective maintenance strategy for patients with chronic obstructive pulmonary diseases: a systematic review
por: Uche-Okoye, Demelum, et al.
Publicado: (2023)

Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis
por: Donohue, James F, et al.
Publicado: (2017)

Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial
por: Thu, Phuong Nguyen Thi, et al.
Publicado: (2021)

Perspectives of patients and healthcare professionals on the impact of telemetrically supported patient self-management for chronic obstructive pulmonary disease (COPD): a qualitative study nested in the TELESCOT trial
por: Pinnock, Hilary, et al.
Publicado: (2012)

The Impact of the Age, Dyspnoea, and Airflow Obstruction (ADO) Index on the Medical Burden of Chronic Obstructive Pulmonary Disease (COPD)
por: Li, Chin-Ling, et al.
Publicado: (2022)

Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care
por: Müllerová, Hana, et al.
Publicado: (2014)

Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review
por: Iheanacho, Ike, et al.
Publicado: (2020)

Characteristics and health burden of the undiagnosed population at risk of chronic obstructive pulmonary disease in China
por: Koch, Marco, et al.
Publicado: (2019)

Economic Burden of Chronic Obstructive Pulmonary Disease Patients in Malaysia: A Longitudinal Study
por: ur Rehman, Anees, et al.
Publicado: (2020)

The Burden of Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases: A Non-Western Perspective
por: Deshmukh, Kartik, et al.
Publicado: (2021)

Global, regional, and national burden of chronic obstructive pulmonary disease from 1990 to 2019
por: Wang, Haifeng, et al.
Publicado: (2022)

Trends in burden of chronic obstructive pulmonary disease in Iran, 1995–2015: findings from the global burden of disease study
por: Hashemi, Seyed Yaser, et al.
Publicado: (2020)

Health Inequality in the Global Burden of Chronic Obstructive Pulmonary Disease: Findings from the Global Burden of Disease Study 2019
por: Li, Haifeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0uukas2vedi0hbdn7j06tfrqe6